Modus CEO Ellen K Donnelly interviewed for BioStock publication

Modus Therapeutics CEO Ellen K Donnelly was recently interviewed for industry publication BioStock.

She joined Modus in April 2017 from Pfizer as Head of Clinical Operations, and has previously worked at Leerink Partners.

Read the full interview with Ellen here